Since high aldehyde dehydrogenase (ALDH) enzymatic activity is considered an important CRC-SC hallmark,36 we assessed the impact of SMYD3 pharmacological inhibition on this feature. This evidence concerns the gene SMYD3 and colorectal carcinoma.